These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 29512199)

  • 1. Chronic neutrophilic leukemia: 2018 update on diagnosis, molecular genetics and management.
    Elliott MA; Tefferi A
    Am J Hematol; 2018 Aug; 93(4):578-587. PubMed ID: 29512199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic neutrophilic leukemia and atypical chronic myeloid leukemia: 2024 update on diagnosis, genetics, risk stratification, and management.
    Szuber N; Orazi A; Tefferi A
    Am J Hematol; 2024 Jul; 99(7):1360-1387. PubMed ID: 38644693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic neutrophilic leukemia 2016: Update on diagnosis, molecular genetics, prognosis, and management.
    Elliott MA; Tefferi A
    Am J Hematol; 2016 Mar; 91(3):341-9. PubMed ID: 26700908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexisting of bone marrow fibrosis, dysplasia and an X chromosomal abnormality in chronic neutrophilic leukemia with CSF3R mutation: a case report and literature review.
    Wu XB; Wu WW; Zhou Y; Wang X; Li J; Yu Y
    BMC Cancer; 2018 Mar; 18(1):343. PubMed ID: 29587671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic neutrophilic leukemia 2014: Update on diagnosis, molecular genetics, and management.
    Elliott MA; Tefferi A
    Am J Hematol; 2014 Jun; 89(6):651-8. PubMed ID: 24845374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular genetics of chronic neutrophilic leukaemia: defining a new era in diagnosis and therapy.
    Elliott MA; Tefferi A
    Curr Opin Hematol; 2014 Mar; 21(2):148-54. PubMed ID: 24335708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic neutrophilic leukemia: 2022 update on diagnosis, genomic landscape, prognosis, and management.
    Szuber N; Elliott M; Tefferi A
    Am J Hematol; 2022 Apr; 97(4):491-505. PubMed ID: 35089603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic neutrophilic leukemia: novel mutations and their impact on clinical practice.
    Tefferi A; Elliott M; Pardanani A
    Curr Opin Hematol; 2015 Mar; 22(2):171-6. PubMed ID: 25575036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic neutrophilic leukemia: 2020 update on diagnosis, molecular genetics, prognosis, and management.
    Szuber N; Elliott M; Tefferi A
    Am J Hematol; 2020 Feb; 95(2):212-224. PubMed ID: 31769070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia.
    Pardanani A; Lasho TL; Laborde RR; Elliott M; Hanson CA; Knudson RA; Ketterling RP; Maxson JE; Tyner JW; Tefferi A
    Leukemia; 2013 Sep; 27(9):1870-3. PubMed ID: 23604229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF3R T618I, SETBP1 G870S, SRSF2 P95H, and ASXL1 Q780* tetramutation co-contribute to myeloblast transformation in a chronic neutrophilic leukemia.
    Qian Y; Chen Y; Li X
    Ann Hematol; 2021 Jun; 100(6):1459-1461. PubMed ID: 33822276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomics of chronic neutrophilic leukemia.
    Maxson JE; Tyner JW
    Blood; 2017 Feb; 129(6):715-722. PubMed ID: 28028025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research progress of additional pathogenic mutations in chronic neutrophilic leukemia.
    Gao J; Han S; Deng B; Deng Y; Gao X
    Ann Hematol; 2024 Aug; 103(8):2591-2600. PubMed ID: 37993585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSF3R mutated myeloid neoplasms: Beyond chronic neutrophilic leukemia.
    Mohamed A; Gao J; Chen YH; Abaza Y; Altman J; Jennings L; Vormittag-Nocito E; Sukhanova M; Lu X; Chen Q
    Hum Pathol; 2024 Jul; 149():66-74. PubMed ID: 38879086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic neutrophilic leukemia: new science and new diagnostic criteria.
    Szuber N; Tefferi A
    Blood Cancer J; 2018 Feb; 8(2):19. PubMed ID: 29440636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular characterization of atypical chronic myeloid leukemia and chronic neutrophilic leukemia].
    Senín A; Arenillas L; Martínez-Avilés L; Fernández-Rodríguez C; Bellosillo B; Florensa L; Besses C; Álvarez-Larrán A
    Med Clin (Barc); 2015 Jun; 144(11):487-90. PubMed ID: 24854193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ASXL1 mutations are frequent and prognostically detrimental in CSF3R-mutated chronic neutrophilic leukemia.
    Elliott MA; Pardanani A; Hanson CA; Lasho TL; Finke CM; Belachew AA; Tefferi A
    Am J Hematol; 2015 Jul; 90(7):653-6. PubMed ID: 25850813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-Occurring CSF3R W791* Germline and Somatic T618I Driver Mutations Induce Early CNL and Clonal Progression to Mixed Phenotype Acute Leukemia.
    Adam FC; Szybinski J; Halter JP; Cantoni N; Wenzel F; Leonards K; Brkic S; Passweg JR; Touw I; Maxson JE; Meyer SC
    Curr Oncol; 2022 Feb; 29(2):805-815. PubMed ID: 35200567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemia.
    Ouyang Y; Qiao C; Chen Y; Zhang SJ
    Oncotarget; 2017 Mar; 8(13):20834-20841. PubMed ID: 28209919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [CSF3R, ASXL1,SETBP1, JAK2 V617F and CALR mutations in chronic neutrophilic leukemia].
    Cui Y; Li B; Jiang Q; Xu Z; Qin T; Zhang P; Zhang Y; Xiao Z
    Zhonghua Xue Ye Xue Za Zhi; 2014 Dec; 35(12):1069-73. PubMed ID: 25543699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.